These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3628478)

  • 1. Methoxyphenamine O-demethylase and 5-hydroxylase: a GLC-ECD assay to study their activities and their inhibition by debrisoquine and sparteine.
    Hawes EM; Roy SD; McKay G; Midha KK
    Pharmacol Ther; 1987; 33(1):73-7. PubMed ID: 3628478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of in vitro metabolism of methoxyphenamine in rats.
    Roy SD
    Xenobiotica; 1990 Jan; 20(1):55-70. PubMed ID: 2327108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-performance liquid chromatographic assays for bufuralol 1'-hydroxylase, debrisoquine 4-hydroxylase, and dextromethorphan O-demethylase in microsomes and purified cytochrome P-450 isozymes of human liver.
    Kronbach T; Mathys D; Gut J; Catin T; Meyer UA
    Anal Biochem; 1987 Apr; 162(1):24-32. PubMed ID: 3605590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinine is a more potent inhibitor than quinidine in rat of the oxidative metabolic routes of methoxyphenamine which involve debrisoquine 4-hydroxylase.
    Muralidharan G; Hawes EM; McKay G; Midha KK
    Xenobiotica; 1991 Nov; 21(11):1441-50. PubMed ID: 1763518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro evidence against the oxidation of quinidine by the sparteine/debrisoquine monooxygenase of human liver.
    Otton SV; Brinn RU; Gram LF
    Drug Metab Dispos; 1988; 16(1):15-7. PubMed ID: 2894945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xenobiotic and endobiotic inhibitors of cytochrome P-450dbl function, the target of the debrisoquine/sparteine type polymorphism.
    Fonne-Pfister R; Meyer UA
    Biochem Pharmacol; 1988 Oct; 37(20):3829-35. PubMed ID: 2903741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effects of anticancer drugs on dextromethorphan-O-demethylase activity in human liver microsomes.
    Le Guellec C; Lacarelle B; Catalin J; Durand A
    Cancer Chemother Pharmacol; 1993; 32(6):491-5. PubMed ID: 8258200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substrate specificity of the form of cytochrome P-450 catalyzing the 4-hydroxylation of debrisoquine in man.
    Boobis AR; Murray S; Kahn GC; Robertz GM; Davies DS
    Mol Pharmacol; 1983 Mar; 23(2):474-81. PubMed ID: 6220203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A human cytochrome P-450 characterized by inhibition studies as the sparteine-debrisoquine monooxygenase.
    Inaba T; Nakano M; Otton SV; Mahon WA; Kalow W
    Can J Physiol Pharmacol; 1984 Jul; 62(7):860-2. PubMed ID: 6498616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective in vivo inhibition by quinidine of methoxyphenamine oxidation in rat models of human debrisoquine polymorphism.
    Muralidharan G; Midha KK; McKay G; Hawes EM; Inaba T
    Xenobiotica; 1989 Feb; 19(2):189-97. PubMed ID: 2786289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quinidine but not quinine inhibits in man the oxidative metabolic routes of methoxyphenamine which involve debrisoquine 4-hydroxylase.
    Muralidharan G; Hawes EM; McKay G; Korchinski ED; Midha KK
    Eur J Clin Pharmacol; 1991; 41(5):471-4. PubMed ID: 1761076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenacetin O-deethylase: an activity of a cytochrome P-450 showing genetic linkage with that catalysing the 4-hydroxylation of debrisoquine?
    Kahn GC; Boobis AR; Brodie MJ; Toverud EL; Murray S; Davies DS
    Br J Clin Pharmacol; 1985 Jul; 20(1):67-76. PubMed ID: 4027138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro metabolism of sparteine by human liver: competitive inhibition by debrisoquine.
    Otton SV; Inaba T; Mahon WA; Kalow W
    Can J Physiol Pharmacol; 1982 Jan; 60(1):102-5. PubMed ID: 7066751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a human liver cytochrome P-450 involved in the oxidation of debrisoquine and other drugs by using antibodies raised to the analogous rat enzyme.
    Distlerath LM; Guengerich FP
    Proc Natl Acad Sci U S A; 1984 Dec; 81(23):7348-52. PubMed ID: 6594694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methoxyphenamine metabolism in rat models of human debrisoquine phenotypes.
    Roy SD; Hawes EM; McKay G; Hubbard JW; Midha KK
    Can J Physiol Pharmacol; 1985 Jul; 63(7):778-81. PubMed ID: 3876145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro inhibition studies of two isozymes of human liver cytochrome P-450. Mephenytoin p-hydroxylase and sparteine monooxygenase.
    Inaba T; Jurima M; Mahon WA; Kalow W
    Drug Metab Dispos; 1985; 13(4):443-8. PubMed ID: 2863108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dichloro-P-nitroanisole O-demethylase--a convenient assay for microsomal mixed function oxidase in isolated rat hepatocytes.
    Hultmark D; Sundh K; Wachtmeister CA; Arrhenius E
    Biochem Pharmacol; 1978; 27(8):1129-34. PubMed ID: 29645
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatic monooxygenase activities in subjects with a genetic defect in drug oxidation.
    Meier PJ; Mueller HK; Dick B; Meyer UA
    Gastroenterology; 1983 Sep; 85(3):682-92. PubMed ID: 6603386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quinidine and the identification of drugs whose elimination is impaired in subjects classified as poor metabolizers of debrisoquine.
    Speirs CJ; Murray S; Boobis AR; Seddon CE; Davies DS
    Br J Clin Pharmacol; 1986 Dec; 22(6):739-43. PubMed ID: 3567021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo administration of H2 blockers, cimetidine and ranitidine, reduced the contents of the cytochrome P450IID (CYP2D) subfamily and their activities in rat liver microsomes.
    Orishiki M; Matsuo Y; Nishioka M; Ichikawa Y
    Int J Biochem; 1994 Jun; 26(6):751-8. PubMed ID: 8063004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.